Nicotinamide mononucleotide administration prevents doxorubicin-induced cardiotoxicity and loss in physical activity in mice

HIGHLIGHTS

• who: Marielle Margier and collaborators from the LGD SARL, Velaux, France Department of Medicine, University of California at San Francisco, San Francisco, CA, USA have published the research work: Nicotinamide Mononucleotide Administration Prevents Doxorubicin-Induced Cardiotoxicity and Loss in Physical Activity in Mice, in the Journal: Cells 2023, 12, x FOR PEER REVIEW of /2023/
• what: This study was designed to investigate whether NMN administration protects against Doxo-induced cardiotoxicity and loss of physical activity in_vivo and to determine the underlying molecular mechanisms by performing an extensive transcriptomic analysis in tissue.
• future: Studies . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.